We applied cotransfection with miR-22 and CD147 in researching their roles in tongue squamous cell carcinoma (TSCC).
The down-regulation of miR-22 results in the up-regulation of CD147.
We demonstrate that CD147 is a downstream factors of miR-22.
The interaction of miR-22 and CD147 may act as a novel therapeutic targets for the treatment of TSCC.